All Results

1 - 12 of 33 results

In this Clinical Coffee Break, Robert Stickgold of Harvard Medical School and Beth Israel Deaconess Medical Center, takes a deeper dive into the role of sleep in forming memories, and regulating immune response and insulin production. He also examines proposed links between sleep and schizophrenia.

celestial vector of a sculpture with psychedelic color palette

Recognize the complexities of managing patients with chronic disease and accompanying depression and/or anxiety.


This Webcast focuses on the identification and treatment of patients with bipolar disorder presenting with symptoms of bipolar I depression. Clinicians will gain insight into the latest data for bipolar depression treatment, learn to select appropriate pharmacologic regimens for treatment, and address gender-specific needs of patients with bipolar depression.

Personality Disorders can be disabling, life threatening illnesses, but even milder forms can interfere with therapeutic alliance, adherence, and treatment success in a general medical practice. In this talk, Mark Petrini, Assistant Clinical Professor of Medicine and Psychiatry at Columbia University Medical Center, provides clinicians with a systematic approach to diagnosis and management of personality disorders in practice and offers strategies for containing affect and behavioral dysregulation.

Discuss best practices to tackle opioid abuse and other pharmacological abuse in your practice. Learn about the latest guidelines and recommendations on screening, responsible prescription and disposal of opioids.


This lecture will provide an overview of recent developments in the treatment of major depressive disorder. The lecture will summarize current antidepressant medication options, and discuss augmentation strategies for patients with difficult-to-treat depression. Safety and efficacy information will be reviewed for several of the new FDA-approved medications for major depressive disorder.

It is commonly difficult to obtain timely mental health referrals in many communities across the country, but many patients seen by primary care practitioners suffer from depression. Hence, primary care clinicians are commonly the first point of contact and treatment for patients with depression. This activity will review procedures to screen for depression, the relative efficacy of different antidepressants, and when to switch or augment antidepressant therapy. In addition, Dr. Smetana will discuss one of the most important factors in drug selection, i.e. how to exploit side effect profiles to advantage of patients.

In this Clinical Coffee Break, Dr. Petrini focuses on specific elements of caring for patients with personality disorders. This activity will provide a practical approach to establishing a contract with the patient as well as an overview of available drug options for patients with personality disorders.

In this activity, Dr. Wyatt will take a deeper dive in the subject of sleep disorders. He will explain in detail the concept of 'sleep switch' and the circadian modulation of the sleep-wake cycle. He will list the causes of daytime sleepiness and the methods to measure it and finally, discuss measures to counteract this increasingly common problem.

person cutting their wrists with small razor blade

Rachel Ballard, MD reviews risk factors for nonsuicidal self-injury (NSSI) behaviors and tools for assessing NSSI risk in the primary care practice.

domestic violence and human trafficking

Learn to assess the signs of physical, sexual and psychological violence in your patients. Dr. Caralis will discuss the latest screening and counseling guidelines recommended by various agencies on ensuring the well-being of women in these situations. This activity is eligible for Florida Board of Medicine’s state-mandated CME requirement.


This activity is part of the ConnectED Learning: Depression curriculum. Primary care providers encounter depressed patients every clinic day. How can a busy practitioner make the important distinctions among these patients: who will respond, to what treatment; and who needs specialty care (psychotherapy and/or medication management)? This session will present a model for recognizing subtypes, especially the mixed sub-type, with an emphasis on using this knowledge to direct management in order to improve outcomes and reduce iatrogenic risk.